MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- Compare Company
- International - indian pharma
- J.B.CHEMICALS - ACTAVIS (US)
J.B.CHEMICALS vs ACTAVIS (US) - Comparison Results
J.B.CHEMICALS Change
JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More
ACTAVIS (US)
Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More
Financials
 J.B.CHEMICALS  ACTAVIS |
| EQUITY SHARE DATA | |||||
|---|---|---|---|---|---|
| J.B.CHEMICALS Mar-18 |
ACTAVIS Dec-18 |
J.B.CHEMICALS/ ACTAVIS |
5-Yr Chart Click to enlarge
|
||
| High | Rs | 363 | 14,106 | - | |
| Low | Rs | 255 | 9,462 | - | |
| Sales per share (Unadj.) | Rs | 169.1 | 3,460.2 | - | |
| Earnings per share (Unadj.) | Rs | 16.6 | -1,114.5 | - | |
| Cash flow per share (Unadj.) | Rs | 23.4 | 364.6 | - | |
| Dividends per share (Unadj.) | Rs | 2.00 | 0 | - | |
| Dividend yield (eoy) | % | 0.6 | 0 | - | |
| Book value per share (Unadj.) | Rs | 172.5 | 14,271.8 | - | |
| Shares outstanding (eoy) | m | 83.57 | 332.60 | - | |
| Bonus/Rights/Conversions | BB | - | - | ||
| Price / Sales ratio | x | 1.8 | 3.4 | 53.7% | |
| Avg P/E ratio | x | 18.6 | -10.6 | -176.1% | |
| P/CF ratio (eoy) | x | 13.2 | 32.3 | 40.8% | |
| Price / Book Value ratio | x | 1.8 | 0.8 | 217.0% | |
| Dividend payout | % | 12.0 | 0 | - | |
| Avg Mkt Cap | Rs m | 25,827 | 3,919,453 | 0.7% | |
| No. of employees | `000 | 3.8 | 16.9 | 22.3% | |
| Total wages/salary | Rs m | 2,511 | 0 | - | |
| Avg. sales/employee | Rs Th | 3,747.4 | 68,099.0 | 5.5% | |
| Avg. wages/employee | Rs Th | 665.7 | 0 | - | |
| Avg. net profit/employee | Rs Th | 367.8 | -21,934.7 | -1.7% | |
| INCOME DATA | |||||
|---|---|---|---|---|---|
| Net Sales | Rs m | 14,135 | 1,150,872 | 1.2% | |
| Other income | Rs m | 366 | 22,009 | 1.7% | |
| Total revenues | Rs m | 14,501 | 1,172,881 | 1.2% | |
| Gross profit | Rs m | 2,178 | 30,159 | 7.2% | |
| Depreciation | Rs m | 570 | 491,973 | 0.1% | |
| Interest | Rs m | 35 | 66,412 | 0.1% | |
| Profit before tax | Rs m | 1,940 | -506,218 | -0.4% | |
| Minority Interest | Rs m | 0 | 0 | - | |
| Prior Period Items | Rs m | 0 | 0 | - | |
| Extraordinary Inc (Exp) | Rs m | 0 | 129,106 | 0.0% | |
| Tax | Rs m | 552 | -6,415 | -8.6% | |
| Profit after tax | Rs m | 1,387 | -370,697 | -0.4% | |
| Gross profit margin | % | 15.4 | 2.6 | 588.1% | |
| Effective tax rate | % | 28.5 | 1.3 | 2,247.0% | |
| Net profit margin | % | 9.8 | -32.2 | -30.5% | |
| BALANCE SHEET DATA | |||||
|---|---|---|---|---|---|
| Current assets | Rs m | 10,470 | 472,028 | 2.2% | |
| Current liabilities | Rs m | 2,749 | 417,571 | 0.7% | |
| Net working cap to sales | % | 54.6 | 4.7 | 1,154.4% | |
| Current ratio | x | 3.8 | 1.1 | 336.9% | |
| Inventory Days | Days | 55 | 20 | 281.8% | |
| Debtors Days | Days | 78 | 66 | 117.1% | |
| Net fixed assets | Rs m | 5,811 | 130,272 | 4.5% | |
| Share capital | Rs m | 167 | 0 | - | |
| Net worth | Rs m | 14,416 | 4,746,811 | 0.3% | |
| Long term debt | Rs m | 0 | 1,671,524 | 0.0% | |
| Total assets | Rs m | 17,649 | 7,420,345 | 0.2% | |
| Interest coverage | x | 56.6 | -6.6 | -854.3% | |
| Debt to equity ratio | x | 0 | 0.4 | 0.0% | |
| Sales to assets ratio | x | 0.8 | 0.2 | 516.4% | |
| Return on assets | % | 8.1 | -4.1 | -196.5% | |
| Return on equity | % | 9.6 | -7.8 | -123.2% | |
| Return on capital | % | 13.7 | -4.8 | -282.9% | |
| CASH FLOW | |||||
|---|---|---|---|---|---|
| From Operations | Rs m | 1,231 | 411,163 | 0.3% | |
| From Investments | Rs m | -208 | 225,881 | -0.1% | |
| From Financial Activity | Rs m | -595 | -705,679 | 0.1% | |
| Net Cashflow | Rs m | 427 | -68,293 | -0.6% | |
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 72.9 Rs / USD
Compare J.B.CHEMICALS With: ADCOCK INGRAM (S. Africa) MYLAN (US) TEVA PHARMA (Israel)
Compare J.B.CHEMICALS With: FRESENIUS KABI ONCO. DR. DATSONS LABS TORRENT PHARMA BIOCON FULFORD INDIA
Today's Market
A Time Correction in the Nifty(Momentum Moves)
The week belonged to the bulls after bears ended the party in February. March started with gains for the bulls but historically, March has been a bears' month.
Related Views On News
J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)
Feb 6, 2020 | Updated on Feb 6, 2020For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.
J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)
May 24, 2019 | Updated on May 24, 2019For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.
J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)
Mar 28, 2019 | Updated on Mar 28, 2019Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.
More Views on NewsMost Popular
It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)
Feb 24, 2021Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)
Feb 25, 2021In this video, I'll show you how to get started on the path to daily trading profits.
The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)
Feb 23, 2021An Indian company founded three decades ago in a garage caught my attention...
Gold 65,000 and Silver 84,000 in 2022
Feb 26, 2021In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.
More
